Valsartan case containing carcinogenic substances will bring negative impacts

Published: 2018-07-17 16:29:00
Updated: 2018-07-17 16:18:17

Started with the Valsartan case, conflicts between doctors and pharmacists have led to discussions about rebates for pharmaceutical companies.

Doctors have opposed to the international proprietary names – this has been argued by them for a while – because they could not trust bioequivalently tes...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.